Read Books Online and Download eBooks, EPub, PDF, Mobi, Kindle, Text Full Free.
Pharmaceutical Biological And Chemical Patents
Download Pharmaceutical Biological And Chemical Patents full books in PDF, epub, and Kindle. Read online Pharmaceutical Biological And Chemical Patents ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Book Synopsis Pharmaceutical, Biological and Chemical Patents by : Maximilian Haedicke
Download or read book Pharmaceutical, Biological and Chemical Patents written by Maximilian Haedicke and published by Beck/Hart. This book was released on 2021-06-17 with total page 250 pages. Available in PDF, EPUB and Kindle. Book excerpt: The topic of chemical and biological patents is of special importance in European and German patent law. The highly technical nature of patents in this area gives rise to special problems for patent lawyers in understanding, for instance, structural alterations like polymorphism and enantiomerism, which lead to a derivative of a substance that is comprised in the prior art. It is a legal question whether and under what circumstances such alterations are treated as novel, and in which cases they are part of the state of the art. Even if a substance is prior art, a new medical use can be patented. Dealing with natural occurrences of a substance is also a problem for patent law, as is the difficulty of understanding how different identifications of a substance and the resulting patents interrelate with each other. This book provides an expert overview of all these questions. Past decisions of the European Court of Justice (ECJ) concerning broccoli and tomato patents, as well as embryonic stem cells, have highlighted the importance of this field of law. Most of the proceedings regarding chemical and biological patents have been held in German courts, and the German jurisprudence has often been the basis for ECJ decisions. Thus, German case law is used to illustrate the commentary.
Book Synopsis Pharmaceutical, Biotechnology, and Chemical Inventions by : Duncan Geoffrey Bucknell
Download or read book Pharmaceutical, Biotechnology, and Chemical Inventions written by Duncan Geoffrey Bucknell and published by Oxford University Press, USA. This book was released on 2011 with total page 2534 pages. Available in PDF, EPUB and Kindle. Book excerpt: Focuses on: Australia, Canada, China, India, Japan, the United States, Europe, France, Germany, Italy, the Netherlands, and the United Kingdom.
Book Synopsis Patents for Chemicals, Pharmaceuticals and Biotechnology by : Philip W. Grubb
Download or read book Patents for Chemicals, Pharmaceuticals and Biotechnology written by Philip W. Grubb and published by Oxford University Press, USA. This book was released on 2004 with total page 552 pages. Available in PDF, EPUB and Kindle. Book excerpt: Previous editions, 1st and 2nd, published under titles : 1st (1982) Patents for chemists ; 2nd (1986) Patents in chemistry and biotechnology ; 3rd edition published in 1999.
Book Synopsis The Generic Challenge by : Martin A. Voet
Download or read book The Generic Challenge written by Martin A. Voet and published by BrownWalker Press. This book was released on 2020-05-01 with total page 240 pages. Available in PDF, EPUB and Kindle. Book excerpt: This Sixth Edition of The Generic Challenge provides important new updates on current regulatory, legal and commercial issues affecting brand and generic pharmaceutical products, including new laws establishing generics for biologics, and changes brought about by the recently enacted America Invents Act. It explains clearly and understandably the roles of patents, FDA regulation of drugs and the Hatch Waxman Act in commercial drug development in light of generic challenges and how improvements in innovative drug products provide benefits to patients while extending the commercial lives of the drugs. There is simply no other book of its kind on this important subject.
Book Synopsis Patent Law in Biotechnology, Chemicals & Pharmaceuticals by : Harold C. Wegner
Download or read book Patent Law in Biotechnology, Chemicals & Pharmaceuticals written by Harold C. Wegner and published by Springer. This book was released on 1992-03-23 with total page 524 pages. Available in PDF, EPUB and Kindle. Book excerpt: A practical guide to patent prosecution and strategy in the US with particular reference to invention in chemicals and biotechnology. The presentation is focused on case law in the US and deals with specific cases. A section is devoted to international patent protection.
Book Synopsis Pharmaceutical Patents in Europe by : Bengt Domeij
Download or read book Pharmaceutical Patents in Europe written by Bengt Domeij and published by Martinus Nijhoff Publishers. This book was released on 2000-03-15 with total page 376 pages. Available in PDF, EPUB and Kindle. Book excerpt: The pharmaceutical industry and patent legislation are inextricably linked. Pharmaceutical companies could not exist without some guarantee that they can recoup the cost of developing a new product. European patent law offers this opportunity, as it allows companies to exclude competition for a specific product for a fixed time scale. In "Pharmaceutical Patents in Europe" the current legal patent situation is examined by a detailed analysis of case law from the European Patent Office (EPO), the international body created with the signing of the European Patent Convention (EPC). Aspects of European patent law not primarily regulated in the EPC, for example Supplementary Protection Certificates and infringement matters, are examined in the setting provided by EC law and domestic laws of European states. This book is written for the reader who understands the main characteristics of patent law and is looking for a practitioner's text on the European pharmaceutical patent law scene. Moreover, the author's remarks can help all readers to look at the field with fresh eyes.
Book Synopsis Intellectual Property Rights and the Life Science Industries by : Graham Dutfield
Download or read book Intellectual Property Rights and the Life Science Industries written by Graham Dutfield and published by World Scientific. This book was released on 2009 with total page 429 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book is a highly readable and entertaining account of the co-evolution of the patent system and the life science industries since the mid-19th century. The pharmaceutical industries have their origins in advances in synthetic chemistry and in natural products research. Both approaches to drug discovery and business have shaped patent law, as have the lobbying activities of the firms involved and their supporters in the legal profession. In turn, patent law has impacted on the life science industries. Compared to the first edition, which told this story for the first time, the present edition focuses more on specific businesses, products and technologies, including Bayer, Pfizer, GlaxoSmithKline, aspirin, penicillin, monoclonal antibodies and polymerase chain reaction. Another difference is that this second edition also looks into the future, addressing new areas such as systems biology, stem cell research, and synthetic biology, which promises to enable scientists to OC inventOCO life forms from scratch.
Book Synopsis Patenting in the Biological Sciences by : R. S. Crespi
Download or read book Patenting in the Biological Sciences written by R. S. Crespi and published by John Wiley & Sons. This book was released on 1982 with total page 230 pages. Available in PDF, EPUB and Kindle. Book excerpt: "A practical guide for research scientists in biotechnology and the pharmaceutical and agrochemical industries."--T.p.
Book Synopsis Patents for Chemicals, Pharmaceuticals, and Biotechnology by : Philip W. Grubb
Download or read book Patents for Chemicals, Pharmaceuticals, and Biotechnology written by Philip W. Grubb and published by Oxford University Press. This book was released on 1999-01-01 with total page 448 pages. Available in PDF, EPUB and Kindle. Book excerpt: The chemicals, pharmaceuticals and biotechnology industries worldwide rely upon being able to patent inventions in order to protect investment in research and development, and to reap commercial rewards. This book guides the reader through the legal and procedural complexities of the British, European, Japanese and US patent systems, and explains in detail the role of patent practitioners (both in-house and in private practice) in maximising the commercial potential of their client's or company's innovative products. This is the third edition of the author's highly acclaimed Patents for Chemists. It provides vital updating and much expanded coverage, while retaining the focus upon the relevant technology and industry practices that sets it apart from more general books on patent law and procedure. Patents for Chemicals, Pharmaceuticals and Biotechnology provides a complete description of the techniques and industry know-how that underlie successful patent practice and portfolio management and will be invaluable to all patent agents and practitioners working in the area of patent law. With its lucid and accessible presentation and practical approach, this book will also be welcomed by scientists, researchers and managers without a legal background. FROM THE REVIEWS OF PREVIOUS EDITIONS `Dr Grubb thoroughly exposes the patent system in a way with which few of his professional peers will quarrel, and his book should be in every chemical/biological patent department library' European Intellectual Property Review `an excellent book for anyone interested in patents' International Review of Industrial Property and Copyright Law `a sensible, practical appraisal of the case law and decisions - easy to read and very informative' CIPA Journal `[A] sterling feature of this work is its truly global perspective' Journal of the Patent and Trademark Office Society (US)
Book Synopsis Intellectual Property Rights and the Life Science Industries by :
Download or read book Intellectual Property Rights and the Life Science Industries written by and published by . This book was released on with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Significant Pharmaceuticals Reported in US Patents by : Thomas F. DeRosa
Download or read book Significant Pharmaceuticals Reported in US Patents written by Thomas F. DeRosa and published by Elsevier. This book was released on 2010-07-07 with total page 701 pages. Available in PDF, EPUB and Kindle. Book excerpt: Significant Pharmaceuticals Reported in US Patents identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the significance of the current treatment agent over previous methods. Pharmaceuticals are included in this review only if at least two of the following criteria were met: Effectiveness in treating an illness, Innovative, ease of preparation, synergy with existing Medications. Pharmaceuticals are reported for 27 separate classes of illness, including: AIDS, Alzheimer's Disease, Cardiovascular Disorders, Diabetes, Epilepsy, Hepatitis C, Osteoporosis, Obesity and Sleep Disorders. Significant Pharmaceuticals Reported in US Patents has been designed to be used as both a reference and synthetic guide for pharmaceutical, medicinal and organic chemists and graduate students. Researchers working in other areas will also find the information valuable as in many instances intermediates or the next generation pharmaceutical are readily convertible into other industrial products including: anti-oxidants, chemical additives, herbicides, polymer precursors, water purification agents. Clear structural depictions of reagents and chemical transformations have been supplied to permit the identification of other future applications. Identifies next generation pharmaceuticals Provides practical preparation methods for each active agent and derivatives Documents the analytical characterization and biological testing results of active agents
Book Synopsis Bioterrorism Countermeasure Development by : Wendy H. Schacht
Download or read book Bioterrorism Countermeasure Development written by Wendy H. Schacht and published by DIANE Publishing. This book was released on 2010-10 with total page 24 pages. Available in PDF, EPUB and Kindle. Book excerpt: Congressional interest in the development of bioterrorism countermeasures remains strong, even after passage of legislation establishing Project BioShield. During the 109th Congress, several bills were introduced (although not enacted) that would have generated additional incentives for the creation of new technologies to counteract potential biological threats. These bills proposed reforms to current policies and practices associated with intellectual property, particularly patents, and the marketing of pharmaceuticals and related products. Contents of this report, updated Nov. 27, 2006: (1) Intro.; (2) Patents and Innovation; (3) Role of Patents in Pharmaceutical/Biomedical R&D; (4) Legislative Developments; (5) Proposals for Change.
Book Synopsis Patent Protection for Second Medical Uses by : Jochen Bühling
Download or read book Patent Protection for Second Medical Uses written by Jochen Bühling and published by Kluwer Law International B.V.. This book was released on 2020-10-13 with total page 806 pages. Available in PDF, EPUB and Kindle. Book excerpt: AIPPI Series, Volume Number 2. The second edition of Patent Protection for Second Medical Uses is a practical guide on the ever-relevant and controversial topic ‘Second Medical Use’ (SMU) patents, which play a significant role in the potential second-line patent protection and have become increasingly important. This edition’s analysis sheds light on the availability of protection for second medical use claims and its legal basis, followed by a detailed look at the specifics of various jurisdictions. Following the abandoning of ‘Swiss-type claims’ at the European Patent Office (EPO), applicants had to develop new filing strategies while such claims are still allowable in a number of national jurisdictions worldwide; the consequences of this have not yet fully been explored in practice. Jurisdictions around the world show significant differences in the treatment of such claims, although they share common approaches in patent law overall. This second edition furnishes a detailed and elaborate analysis, providing clarity, insight and guidance on legal issues and practical implications of SMU claims in twenty-four jurisdictions (the EPO and twenty-three individual countries). What’s in this book: This book, published under the aegis of the esteemed International Association for the Protection of Intellectual Property (AIPPI), contains a chapter-wise analysis by carefully chosen authors known for their expertise and experience in this field. Each chapter highlights such issues and topics as the following: availability and scope of protection; validity of claims; enforcement; infringement and investigations; and procedural aspects and tactical recommendations. The AIPPI studied certain aspects of second medical use claims on the occasion of its Congress in Toronto in 2014. This led to its Resolution Q 238 – ‘Second medical use and other second indication claims’, which triggered this comparative law analysis and a copy of which is found at the end of this book. How this will help you: This book is an enlightening compendium of contributions from across the globe. It not only renders guidance to interested legal practitioners when filing a patent application and assessing risks of conflict with existing patents or patent applications but also explains the key issues and contains practical advice when enforcing such claims or defending against an action. Also, this book will prove to be of immense practical interest for patent lawyers and patent attorneys and for the industries involved, applicants for pharmaceutical patents and third parties.
Book Synopsis The Law of Chemical and Pharmaceutical Invention by : Jerome Rosenstock
Download or read book The Law of Chemical and Pharmaceutical Invention written by Jerome Rosenstock and published by Wolters Kluwer Law and Business. This book was released on 2012 with total page 2318 pages. Available in PDF, EPUB and Kindle. Book excerpt: Law of Chemical and Pharmaceutical Invention, Fourth Edition is the only resource that covers both patent and nonpatent protection for chemical and pharmaceutical inventions, including: Fundamentals and Protection Eligibility Utility Patent Claims Design Patents Eligibility of Genetic Engineering Inventions Nonpatent Eligibility and Protection Enforcement of Patent Rights Infringement Defenses: Noninfringement, Invalidity, Unenforceability This unique, comprehensive two-volume reference clarifies the concepts and processes surrounding both patent and nonpatent protection. It includes extensive use of diagrams of chemical structures to eliminate confusion. And it directly quotes case law to make necessary points and provide legal accuracyand—rather than interpretation. Youand’ll find full and clear explications on: Patent basis and terms Nonpatent protection The exhaustion doctrine Extension, infringement, remedies And more! Law of Chemical and Pharmaceutical Invention, Fourth Edition is invaluable for its analysis of patent and nonpatent protection alone. But it is also the only single resource to deliver guidance on all of these important topics: Managing litigation expenses and obtaining reliable litigation insurance Extending your patent life through the filing of provisional patent applications Securing design patents to protect your brand Understanding the exhaustion doctrine and its implications Determining whether your patent is part of a standard-setting organization
Book Synopsis Patents for Chemicals, Pharmaceuticals, and Biotechnology by : Philip W. Grubb
Download or read book Patents for Chemicals, Pharmaceuticals, and Biotechnology written by Philip W. Grubb and published by Oxford University Press, USA. This book was released on 2016 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: The nature and origins of patent rights -- Historical developments -- Harmonization of patent law -- What can be patented -- Filing a patent application -- Obtaining a granted patent : patent cooperation treaty procedure -- Obtaining a granted patent : European patent office procedure -- Obtaining a granted patent : national procedures -- Maintaining a patent in force and extending the patent term -- Enforcing patent rights -- Invalidity and amendment of granted patents -- Chemical inventions -- Pharmaceutical inventions -- Biotechnological inventions -- Patenting of genes, plants, and animals -- The patent practitioner and his function -- Drafting the patent specification -- Drafting the claims -- Prosecution of the patent application to grant -- Inventorship, ownership, and compensation -- Commercial exploitation of patents -- How to catch the infringer and how not to be caught -- Patent aspects of licensing -- Patents and competition law : United Kingdom and European Union -- Patents and competition law : United States
Download or read book Drug Repurposing written by David Cavalla and published by Royal Society of Chemistry. This book was released on 2022-01-31 with total page 351 pages. Available in PDF, EPUB and Kindle. Book excerpt: Drug repurposing is the development of existing drugs for new uses: given that 9 in 10 drugs that enter drug development are never marketed and therefore represent wasted effort, it is an attractive as well as inherently more efficient process. Three repurposed drugs can be brought to market for the same cost as one new chemical entity; and they can also be identified more quickly, an important benefit for patients whose diseases are progressing faster than therapeutic innovation. But repurposing also requires a fresh look at configuring pharmaceutical R&D, considering clinical, regulatory and patent issues much earlier than would otherwise be the case; a holistic gedanken experiment almost needs to be undertaken at the very start of any repurposing development. In addition to new ways of thinking, the discovery of repurposing opportunities can take advantage of artificial intelligence techniques to match the perfect new use for an existing drug. And while repurposing of medicines has been in the mind of every doctor since Hypocrates, modern clinical practice will simply have to adapt to new repurposing techniques in an age where the number of known diseases is increasing much faster than the healthcare dollars available.
Book Synopsis Chemical Information 2 by : Harry R. Collier
Download or read book Chemical Information 2 written by Harry R. Collier and published by Springer Science & Business Media. This book was released on 2012-12-06 with total page 234 pages. Available in PDF, EPUB and Kindle. Book excerpt: This volume contains the full text of twenty ofthe twenty-one papers given at the Montreux 1990 International Chemical Information Conference in Mon treux, Switzerland between 24 and 26 September 1990. The one paper that is omitted was not received in time for incorporation in these Proceedings. The papers reflect the diverse nature of chemical information, an information field that has usually been in the forefront of applying new technology to solving information problems. In many ways, the electronic information revolution is still in its infancy; during the Montreux conferences, we intend to chart the dynamic interaction between chemical information and new technology. One publishing problem with an information field that moves so rapidly is the constant need to make printed information available within weeks or months of it being written. The majority of papers in this volume were written during the period May - July 1990. Conventional publishing, of course, allows authors time to proof-read their texts, to make changes and corrections and allows time for the contents to be indexed extensively. Time, however, is a luxury in the case of conference proceedings in the area of chemical, pharmaceutical and patent information at the beginning of the 1990s. We hope readers will appreciate the necessary trade-off that has had to take place between text thoroughly prepared, revised, indexed and corrected; and text that is available for general readership soon after it was written.
